Speaker illustration

Doctor Daniel Jorge Nascimento Matos

Hospital de Santa Cruz, Carnaxide (Portugal)

Ventricular tachycardia ablation in nonischemic cardiomyopathy

Event: ESC Congress 2021 - The Digital Experience

Topic: Ablation of Ventricular Arrhythmias

Session: Ventricular arrhythmias and sudden cardiac death e-posters

Thumbnail

Ventricular tachycardia ablation in nonischemic cardiomyopathy

Event: EHRA 2021

Topic: Ablation of Ventricular Arrhythmias

Session: ePoster session

Thumbnail

A new electrophysiological triad for atrial flutter critical isthmus identification and localization

Event: EHRA 2021

Topic: Catheter Ablation of Arrhythmias

Session: ePoster session

Thumbnail

Electrical anatomy of the left atrium during atrial fibrillation

Event: EHRA 2021

Topic: Rhythm Control, Catheter Ablation

Session: ePoster session

Thumbnail

Combined endocardial and epicardial ventricular tachycardia ablation for ischemic and nonischemic dilated cardiomyopathy

Event: ESC Congress 2020

Topic: Ablation of Ventricular Arrhythmias

Session: Novel Knowledge in Advanced Treatment of Life Threatening Ventricular Arrhythmia

Thumbnail

Relationship between epicardial fat and left atrium fibrosis in patients with atrial fibrillation

Event: ESC Congress 2020

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation ePosters

Thumbnail

Epicardial fat volume outperforms classic clinical scores for predicting atrial fibrillation relapse after pulmonary vein isolation

Event: ESC Congress 2020

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation ePosters

Thumbnail

A machine-learning algorithm to predict atrial fibrillation recurrence after a pulmonary vein isolation procedure

Event: ESC Congress 2020

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation ePosters

Thumbnail

Who is too old for epicardial fat volume quantification?

Event: ESC Congress 2020

Topic: Rhythm Control, Catheter Ablation

Session: Atrial Fibrillation ePosters

Thumbnail

Long term safety analysis of transvenous vs subcutaneous implantable cardioverter defibrillators: a propensity score matched analysis

Event: EHRA 2019

Topic: Device Treatment

Session: Antibradycardia Pacing

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb